Chlorothiazide sodium
- Product NDC
- 68083-614
- 11-digit product format
- 680830614
- Labeler code
- 68083
- Product ID
- 68083-614_e19fe503-9b2e-4db0-b4ee-0fb9ec9c11c2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlorothiazide sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA218630
- Marketing category
- ANDA
- Marketing start
- 2024-10-03
- Substance
- CHLOROTHIAZIDE SODIUM
- Active strength
- 500 mg/18mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data
- Finished product
- Yes
- Brand name base
- Chlorothiazide sodium
- Listing expiration
- 2026-12-31
Active Ingredients
| Ingredient | Strength |
|---|
| CHLOROTHIAZIDE SODIUM | 500 mg/18mL |
Harmonized Identifiers
| Field | Values |
|---|
| Unii | SN86FG7N2K |
| Rxcui | 484152 |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| SN86FG7N2K | CHLOROTHIAZIDE SODIUM | 7085-44-1 | CHLOROTHIAZIDE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68083-614-01 | 68083061401 | 1 VIAL in 1 CARTON (68083-614-01) / 18 mL in 1 VIAL | 1 vial | 2024-10-03 | No | No | Current |